Cortical Activity and Gait Function for Robotic Gait Training in Hemiparetic Stroke

February 9, 2020 updated by: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea

Effects of Robotic Gait Training on Cortical Activity and Gait Function in Hemiparetic Stroke

Effects of robot-assisted gait training on cortical activity and gait function in hemiparetic stroke

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Hemiplegic patients secondary to first cerebrovascular accidents
  • Functional ambulation category score 3
  • 3 months ≤ Onset ≤ 12 months
  • Korean Mini-Mental State Examination score > 24

Exclusion Criteria:

  • History of surgery of affected lower limb
  • Fracture of affected lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot-assisted gait training
experimental group that applied the end-effector robot-assisted gait training
intervention with robot-assisted gait training
Active Comparator: Treadmill gait training
control group that applied the treadmill gait training
intervention with treadmill gait training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxygenated hemoglobin levels
Time Frame: 4 weeks from baseline
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
4 weeks from baseline
Range of motion of ankle, knee, and hip joint
Time Frame: 4 weeks from baseline
ankle, knee, and hip joint motion of sagittal plane during gait
4 weeks from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxygenated hemoglobin levels
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Range of motion of ankle, knee, and hip joint
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
ankle, knee, and hip joint motion of sagittal plane during gait
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Berg Balance Scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Berg Balance Scale assess the functional balance ability of participants with observation of 14 tasks, representing functional movements common in daily life. Each task is scored on a five-point scale (0-4) following the guidelines of the test developers, and the maximum score on this test is 56 which indicates balance ability within the normal range.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Fugl-Meyer Assessment
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity. It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
10m walk test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Functional ambulation category
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Falls efficacy scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Korean version of Falls efficacy scale asks subjects to rank their confidence about their ability not to fall while performing a variety of activities of daily living with a maximum score of 100
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Beck depression inventory
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
21-question multiple-choice self-report inventory, one of the most widely used psychometric tests
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Stroke impact scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
health-related quality of life poststroke across 8 domains using a 5-point Likert scale, with the score ranging from 0 to 100 and a higher score indicating better health status
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Dynamic gait index
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
a clinical tool to assess gait, balance and fall risk
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Timed up and go test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
a simple test used to assess a person's mobility and requires both static and dynamic balance
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
modified Barthel index
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Measure of physical disability used widely to assess behaviour relating to activities of daily living for stroke patients
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
dual task - COWAT
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Controlled Oral Word Association Test, abbreviated COWA or COWAT, is a verbal fluency test that measures spontaneous production of words belonging to the same category or beginning with some designated letter.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
dual task - digit span test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
The digit span test is a way of measuring the storage capacity of a person's working memory.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Electromyography of lower extremities
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Muscle activity of tibialis anterior, medial gastrocnemius, vastus medialis, biceps femoris, gluteus medius during gait.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Plantar pressure
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Plantar pressure (great toe, little toe, medial meta, lateral meta, medial arch, lateral arch, heel) during gait
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Spatiotemporal gait parameter data
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
step length, step time, swing time, double limb support time during gait
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
deoxygenated hemoglobin levels
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
total hemoglobin levels
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Balance test using force plate
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Static standing balance as measured using a force plate: Changes in center-of-pressure velocity and area
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

November 30, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

August 12, 2019

First Submitted That Met QC Criteria

August 12, 2019

First Posted (Actual)

August 13, 2019

Study Record Updates

Last Update Posted (Actual)

February 11, 2020

Last Update Submitted That Met QC Criteria

February 9, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Robot-assisted gait training

3
Subscribe